1 Min Read Psoriasis
7 月 28, 2026Psoriasis
7 月 28, 2026
Care Framework & Diagram
The words 'skin disease' caused psoriasis to be underestimated for decades
编辑部精选 · 照护框架与示意图
Acute Infection (Full Mobilization)
Pathogen cleared — but the body doesn’t switch off instantly.
1. Cytokine Afterwave
Inflammation chemicals (IL‑6, TNF‑α) stay mildly elevated for weeks.
Blood tests may look “normal” but levels are still above what you can feel.
2. Neuroinflammation
Those chemicals reach the brain and disrupt mood‑regulating chemistry — causing brain fog, poor sleep, and low motivation.
3. Mitochondrial Damage
Immune “cleanup” chemicals damage your cells’ energy factories, so even small activity takes hours or days to recover from — not overnight.
4. HPA Axis Dysregulation
The morning cortisol spike that normally gets you going weakens — making it hard to start the day and worsening sleep.
The PEM Trap (Post‑Exertional Malaise)
Good day → overdo it → crash → rest → repeat.
This cycle is the direct result of mechanism 3: damaged energy factories mean a burst of activity now costs you days later, not hours.
Pacing Beats Pushing
- Stay below about 80% of your energy budget for the day — this is what breaks the crash cycle.
- Graded exercise therapy (pushing through it) can make Long COVID worse — avoid forcing activity up.
Frequently Asked Questions
Is psoriasis contagious?
Absolutely not. Psoriasis is an autoimmune disease, not an infectious disease. Skin lesions have no infectivity. This is the most common misconception and the root of social discrimination that many patients face.
My child developed psoriasis — did I pass it on?
There's a genetic factor but it's not simple inheritance. If one parent has psoriasis, child risk is approximately ten percent; if both parents, approximately fifty percent. But over half of psoriasis patients have no family history — genetics provides susceptibility, not destiny. Environmental factors (like repeated streptococcal infection) are especially important in triggering childhood psoriasis.
Are biologics safe? What are the long-term risks?
Long-term follow-up data (over ten years) shows biologics' overall safety is acceptable with appropriate screening and monitoring. Main concerns include infection risk (especially tuberculosis — must be screened before use), injection site reactions, and specific drug-specific risks (anti-IL-17 class may worsen in IBD patients). Compared to the cardiovascular and systemic risks of severe psoriasis itself, benefit usually exceeds risk.
Can nail psoriasis be treated?
Nail psoriasis (pitting, nail separation, subungual hyperkeratosis) is usually harder to treat than skin psoriasis; topical medication effects are limited. Biologics (especially anti-IL-17A and anti-IL-23 types) have some effect on nail psoriasis but improvement is slower than skin lesions, requiring over six months to see significant change.
Which is harder to treat — psoriasis or psoriatic arthritis?
Both need serious management, but psoriatic arthritis (PsA) treatment is more urgent — because joint erosion damage is irreversible; delayed treatment causes permanent joint functional damage. PsA symptoms include joint pain, morning stiffness (over thirty minutes), 'sausage fingers' (entire finger/toe swelling), heel or sole pain, and spine symptoms. Any psoriasis patient with these symptoms should promptly seek rheumatology evaluation.